A prior meta-analysis showed that antidepressant use in major depressive disorder was
associated with reduced plasma levels of several pro-inflammatory mediators, which have been …

Background & Aims The impact of chronic liver disease on outcomes in patients with COVID-19
is uncertain. Hence, we aimed to explore this association. Methods We explored the …

Several medications commonly used for a number of medical conditions share a property of
functional inhibition of acid sphingomyelinase (ASM), or FIASMA. Preclinical and clinical …

Background Haloperidol, a widely used antipsychotic, has been suggested as potentially
useful for patients with COVID-19 on the grounds of its in-vitro antiviral effects against SARS-…

Objective To examine the association between antidepressant use and the risk of intubation
or death in hospitalized patients with COVID-19. Design Multicenter observational …

Aims To examine the association between dexamethasone use and mortality among
patients hospitalized for COVID‐19. Methods We examined the association between …

Objective Preliminary data from different cohorts of small sample size or with short follow‐up
indicate poorer prognosis in people with obesity compared with other patients. This study …

Purpose The role of angiotensin receptor blockers (ARB), angiotensin-converting enzyme
inhibitors (ACEi), or other antihypertensive agents in the case of Covid-19 remains …

Introduction Chlorpromazine has been suggested as being potentially useful in patients
with coronavirus disease 2019 (COVID-19) on the grounds of its potential antiviral and anti-…

The acid sphingomyelinase (ASM)/ceramide system may provide a useful framework for
better understanding SARS-CoV-2 infection and the repurposing of psychotropic medications …